Edgewater Capital Partners

Edgewater targets lower-middle-market companies in performance materials, components, and services. The firm focuses on four main sectors: specialty industrials, life sciences, advanced materials, and specialty chemicals. Its investment strategy includes buyouts, corporate divestitures, growth equity, management buyouts, spin-offs, and succession-driven transactions.

Edgewater relies on over two decades of sector-specific experience and relationships within niche industrial and life-science markets. The firm emphasizes its Midwestern values and reputation for certainty-to-close when working with founders and corporate sellers. Proprietary deal flow often comes through the technical networks of its portfolio executives and operating partners.

As a private equity firm, Edgewater manages committed fund structures, though specific fund sizes and vintages are not publicly disclosed. The firm acquires controlling interests in portfolio companies, typically with an operational-improvement thesis centered on technology, infrastructure, and team investments.

While Edgewater is headquartered in Cleveland, Ohio, its portfolio spans several U.S. states including California, Texas, Ohio, Vermont, and Maine. Internationally, the firm holds assets in Canada through GL Chemtec in Oakville, Ontario, and in India through REV Clinical's operations in Ahmedabad.

Edgewater does not publicly outline a formal co-investment program. The firm typically executes control-oriented transactions independently, drawing on its internal team and operating partners to execute value-creation plans in acquired companies.